[HTML][HTML] Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color

EC Davis, VD Callender - The Journal of clinical and aesthetic …, 2010 - ncbi.nlm.nih.gov
Postinflammatory hyperpigmentation is a common sequelae of inflammatory dermatoses
that tends to affect darker skinned patients with greater frequency and severity …

The pathogenesis of melasma and implications for treatment

O Artzi, T Horovitz, E Bar‐Ilan… - Journal of cosmetic …, 2021 - Wiley Online Library
Background Melasma is a complex and poorly understood disorder, with high rates of
treatment failure and recurrences. Objectives We aimed to review the current knowledge of …

[HTML][HTML] New oral and topical approaches for the treatment of melasma

PE Grimes, S Ijaz, R Nashawati, D Kwak - International journal of women's …, 2019 - Elsevier
Melasma is a common, therapeutically challenging, and universally relapsing disorder of
hyperpigmentation that is most often observed in women and individuals with Fitzpatrick …

Postinflammatory hyperpigmentation: etiologic and therapeutic considerations

VD Callender, S St. Surin-Lord, EC Davis… - American journal of …, 2011 - Springer
Postinflammatory hyperpigmentation (PIH) is a reactive hypermelanosis and sequela of a
variety of inflammatory skin conditions. PIH can have a negative impact on a patient's quality …

Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo …

S Farshi, P Mansouri, B Kasraee - Journal of dermatological …, 2018 - Taylor & Francis
Background: Melasma is a difficult-to-treat hyperpigmentary disorder. Very few studies have
been performed regarding the efficacy of cysteamine in the treatment of melasma. Objective …

Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double‐blind placebo‐controlled trial

P Mansouri, S Farshi, Z Hashemi… - British Journal of …, 2015 - academic.oup.com
Background Melasma is a difficult‐to‐treat hyperpigmentary disorder. While cysteamine is a
known potent depigmenting agent, its efficacy in treating melasma has not been tested …

Prevalence of pigmentary disorders and their impact on quality of life: a prospective cohort study

A Taylor, M Pawaskar, SL Taylor… - Journal of cosmetic …, 2008 - Wiley Online Library
Background Pigmentary disorders are commonly seen in dermatology practice and can
have a negative psychosocial impact on patients. Objective This study aims to examine the …

[PDF][PDF] Treatment of hyperpigmentation

H Woolery-Lloyd, JN Kammer - Seminars in cutaneous medicine …, 2011 - cdn.mdedge.com
Hyperpigmentation is a common dermatologic condition that is seen in all skin types but is
most prominent in skin of color. In skin of color, any inflammation or injury to skin can almost …

The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: A randomized controlled trial

M Gheisari, S Dadkhahfar, E Olamaei… - Journal of cosmetic …, 2020 - Wiley Online Library
Background The management of melasma is still challenging, and new treatment modalities
with favorable side effect profile are required. Methimazole, a peroxidase inhibitor, seems to …

Successful treatment of hydroquinone‐resistant melasma using topical methimazole

J Malek, A Chedraoui, D Nikolic, N Barouti… - Dermatologic …, 2013 - Wiley Online Library
Melasma is an acquired hyperpigmentation skin disorder in sun‐exposed areas. It occurs
almost exclusively over the face, and is most commonly seen in women. Several …